Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
cost-effectiveness study
Pear's reSET-O DTx lowers costs, enhances quality of life in new study
By
Emily Olsen
|
02:41 pm |
September 01, 2021
Using the reSET-O app in addition to other opioid treatments lowered healthcare costs by $1,014 and added 0.003 quality-adjusted life years compared with treatment alone.
